RT @RichardPAConway: Askanase et al. Phase 2 RCT Cenerimod (S1P modulator) in SLE. Primary endpoint not met. Some sugges
Tweet Content
Askanase et al. Phase 2 RCT Cenerimod (S1P modulator) in SLE. Primary endpoint not met. Some suggestion of efficacy at highest 4mg dose. But if its already like this in a phase 2, I doubt a phase 3 will bring better results @RheumNow #ACR22 Abstr#1656 https://t.co/p4fcKW3cYD https://t.co/ha8xqeW6Xk
Links
Efficacy and Safety of Cenerimod in Patients with Moderate to Severe Systemic L…
https://acrabstracts.org/abstract/efficacy-and-safety-of-cenerimod-in-patients-…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off